NASDAQ:CPRX News 15 December 2025

Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

Catalyst Pharmaceuticals shares fell 3% to $23.33 in thin afternoon trading Tuesday, extending a two-day slide and leaving the stock about 12% below its June high. Biotech ETFs underperformed the broader market, with the iShares Nasdaq Biotechnology ETF down 1.2%. Investors are awaiting the Federal Reserve’s meeting minutes and Catalyst’s next update in January.

30 December 2025

NASDAQ:CPRX·Pharmaceuticals·Stock Market

Catalyst Pharmaceuticals CPRX Stock News, Forecasts and Analyst Outlook for December 15, 2025

December 15, 2025 — Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX) is getting fresh attention on Monday as the company tees up a high-visibility appearance at the J.P. Morgan Healthcare Conference early next year, while traders and analysts continue to debate the stock’s “next leg” after a strong 2025 run in rare-disease commercialization. At the same time, the backdrop around Catalyst is unusually rich with “moving parts” that matter to stockholders: a large cash position, an active share repurchase authorization, a product portfolio that’s growing (FIRDAPSE and AGAMREE) while also facing predictable generic pressure (FYCOMPA), and Wall Street price targets that still

15 December 2025

NASDAQ:CPRX·Pharmaceuticals

American Express stock price: AXP ends Friday up, but the real read starts with the new 10-K

7 February 2026

American Express shares closed up 1.28% at $359.15 Friday, trading above average volume as the S&P 500 and Dow also rallied. The company filed its annual 10-K report on Feb. 6. Anna Marrs, a senior executive, exercised options and sold 27,425 shares at about $350 each, according to a Form 4 filing.

UnitedHealth stock price ticks up to $276.65 as insurer cost signals shift — what investors watch next week

7 February 2026

UnitedHealth shares closed up 3% at $276.65 Friday, rebounding after Molina Healthcare’s weak 2026 outlook rattled managed-care stocks. Centene later issued a stronger 2026 profit forecast, easing some pressure. UnitedHealth traded between $263.00 and $277.74 during the session. Investors await Humana’s results Feb. 11 and a Medicare Advantage rate decision April 6.

Intel stock (INTC) jumps to $50.59 — the two headlines traders will watch before Monday

7 February 2026

Intel shares jumped 4.87% to $50.59 Friday, rebounding as U.S. stocks rallied. Reports of server chip shortages in China and Intel’s planned $100–$150 million investment in AI startup SambaNova drew investor attention. Nvidia and Broadcom also surged. Delayed U.S. jobs and inflation data are due next week.

Applied Materials stock jumps 6% into a packed week — what matters before Monday

7 February 2026

Applied Materials shares jumped 6.1% to $322.51 Friday as chip stocks rebounded, ending the week 6% below their 52-week high. Investors await Applied’s earnings report on Feb. 12 and new U.S. economic data, with export controls and China exposure still seen as key risks.

NASDAQ:CPRX News 15 December 2025 - 30 December 2025

Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

Catalyst Pharmaceuticals CPRX Stock News, Forecasts and Analyst Outlook for December 15, 2025

Stock Market Today

American Express stock price: AXP ends Friday up, but the real read starts with the new 10-K

UnitedHealth stock price ticks up to $276.65 as insurer cost signals shift — what investors watch next week

Intel stock (INTC) jumps to $50.59 — the two headlines traders will watch before Monday

Applied Materials stock jumps 6% into a packed week — what matters before Monday